ArticlePharmaceuticals (Basel, Switzerland)2026

Zhuangyang Bushen Pill Attenuates Renal Injury in Chronic Glomerulonephritis by Suppressing the MAPK Signaling Pathway.

Ying Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.